Synbio Technologies由一群充滿激情的合成生物學家於2013年成立，他們擁有數十年的行業經驗和提供高成本效益的DNA解決方案的良好記錄。目前擁有超過 250 名科研人員，其最先進的生產設施已通過最高 DNA 製造標準（ISO9001 和 ISO13485）認證。 Synbio Technologies的成立只為一個使命：通過提供最先進和高成本效益的DNA技術平台，增強科學發現和藥物創新能力。該公司已經開發了全方位的DNA讀取（測序）、DNA書寫（合成）和DNA編輯（工程）能力，並在全球向研究人員提供了令人滿意的解決方案，包括診斷性DNA探針、精準醫學、蛋白質生產、抗體發現、疫苗開發、新型酶、分子育種等各種應用。
Synbio Technologies has developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. The company’s services cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology work, including but not limited to:
- Oligo synthesis
- Gene synthesis
- Subcloning & PCR cloning
- Plasmid preparation (up to gram scale)
- Mutagenesis
- DNA variant libraries (Permutation, random, trimer libraries, etc.)
- CRISPR sgRNA
- Protein expression and purification in multiple systems (E.coli, yeast, insect and mammalian cells)
